Evidence map›Paper›PMID 40102408›Full record

ArticleNature communications2025

Electronic vascular conduit for in situ identification of hemadostenosis and thrombosis in small animals and nonhuman primates.

Zhirong Liu, Chuyu Tang, Nannan Han, Zhuoheng Jiang, Xi Liang, Shaobo Wang, Quanhong Hu, Cheng Xiong, Shuncheng Yao, Zhuo Wang and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Improved Cardiac Function and Glycemic Control in Elderly Diabetic Patients Through Structured Case Management After CABG.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Trial
  2. Review
  3. Soft robotic devices for cardiovascular medicine.Nature reviews. Cardiology · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zhirong Liu *Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
Chuyu Tang *Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
Nannan Han *Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhuoheng JiangBeijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
Xi LiangBeijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
Shaobo WangBeijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
Quanhong HuBeijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
Cheng XiongBeijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
Shuncheng YaoBeijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
Zhuo WangBeijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
Zhong Lin WangBeijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China. zhong.wang@mse.gatech.edu.ORCID http://orcid.org/0000-0002-5530-0380
Duohong ZouDepartment of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. zouduohongyy@163.com.
Linlin LiBeijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China. lilinlin@binn.cas.cn.ORCID http://orcid.org/0000-0003-1041-4533

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients suffering from coronary artery disease (CAD) or peripheral arterial disease (PAD) can benefit from bypass graft surgery. For this surgery, arterial vascular grafts have become promising alternatives when autologous grafts are inaccessible but suffer from numerous postimplantation challenges, particularly delayed endothelialization, intimal hyperplasia, high risk of thrombogenicity and restenosis, and difficulty in timely detection of these subtle pathological changes. We present an electronic vascular conduit that integrates flexible electronics into bionic vascular grafts for in situ, real-time and long-term monitoring for hemadostenosis and thrombosis concurrent with postoperative vascular repair. Following bypass surgery, the integrated bioelectronic sensor based on the triboelectric effect enables monitoring of the blood flow in the vascular graft and identification of lesions in real time for up to three months. In male nonhuman primate cynomolgus monkeys, the electronic vascular conduit, with an integrated wireless signal transmission module, enables wireless and real-time hemodynamic monitoring and timely identification of thrombi. This electronic vascular conduit demonstrates potential as a treatment-monitoring platform, providing a sensitive and intuitive monitoring technique during the critical period after bypass surgery in patients with CAD and PAD.

Indexed as

Blood Vessel ProsthesisThrombosisAnimalsCoronary Artery DiseaseElectronicsHumansMacaca fascicularisMalePeripheral Arterial Disease

Identifiers

PMID40102408
PMCPMC11920275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.